Loading data
NEUNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.73 bn USD | 2.79 bn USD | 2.7 bn USD | 2.76 bn USD | 2.36 bn USD |
| Cost of revenue | 1.87 bn USD | 1.9 bn USD | 1.93 bn USD | 2.12 bn USD | 1.81 bn USD |
| Gross profit | 857.4 m USD | 886.35 m USD | 772.51 m USD | 640.5 m USD | 547.71 m USD |
| Research and development expense | 132.09 m USD | 124.9 m USD | 138 m USD | 140.25 m USD | 143.95 m USD |
| Selling, general and administrative expense | 181.58 m USD | 171.41 m USD | 151.47 m USD | 145.11 m USD | 145.97 m USD |
| Operating profit | 543.73 m USD | 590.04 m USD | 483.05 m USD | 355.14 m USD | 257.78 m USD |
| Interest expense | 39.69 m USD | 57.37 m USD | 37.36 m USD | 35.2 m USD | 34.22 m USD |
| Profit before tax | 560.56 m USD | 584.11 m USD | 488.96 m USD | 347.73 m USD | 247.55 m USD |
| Income tax expense | 141.82 m USD | 121.69 m USD | 100.1 m USD | 68.2 m USD | 56.64 m USD |
| Net income (reported basis) | 418.75 m USD | 462.41 m USD | 388.86 m USD | 279.54 m USD | 190.91 m USD |
| Net income attributable to common shareholders | 417.13 m USD | 460.76 m USD | 387.53 m USD | 278.66 m USD | 190.45 m USD |
| Basic earnings per share | 44.44 USD/share | 48.22 USD/share | 40.44 USD/share | 27.77 USD/share | 17.71 USD/share |
| Diluted earnings per share | 44.44 USD/share | 48.22 USD/share | 40.44 USD/share | 27.77 USD/share | 17.71 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.